Olema Pharmaceuticals, Inc. Contracts & Agreements

49 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment Number No. 2 to the Drug Discovery Collaboration and License Agreement by and between the Registrant and Aurigene Oncology Limited, dated November 15, 2024
Olema Pharmaceuticals, Inc.
Biotechnology
2025
Amendment Number No. 1 to the Drug Discovery Collaboration and License Agreement by and between the Registrant and Aurigene Oncology Limited, dated May 2, 2024
Olema Pharmaceuticals, Inc.
Biotechnology
2025
Clinical Trial Collaboration and SupplyAgreement by and between theRegistrant and Novartis Pharma AG,dated November 29, 2024
Olema Pharmaceuticals, Inc.
Biotechnology
2025
Offer Letter by and between the Registrant and Shawnte Mitchell, dated January 27, 2025
Olema Pharmaceuticals, Inc.
Biotechnology
2025
Olema Pharmaceuticals, Inc. 2022 Inducement Plan, as amended December 5, 2024
Olema Pharmaceuticals, Inc.
Biotechnology
2025
OLEMA PHARMACEUTICALS, INC. $100,000,000 COMMON STOCK SALES AGREEMENT
Stock Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2025
Form of Exchange Warrant
Warrant Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
NY
2025
Form of Securities Purchase Agreement
Purchase Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
NY
2024
Form of Pre-Funded and Exchange Warrant
Warrant Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
NY
2024
Olema Pharmaceuticals, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2024
First Amendment to Loan and Security Agreement by and between the Registrant and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, dated June 28, 2024
Loan Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2024
Amendment No. 2 to Amended and Restated Clinical Collaboration and Supply Agreement, by and between the Company and Novartis Institutes for BioMedical Research, Inc., dated March...
Collaboration Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2024
OLEMA PHARMACEUTICALS, INC. $100,000,000 COMMON STOCK SALES AGREEMENT
Stock Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2024
Sales Agreement by and between Registrant and Cowen and Company, LLC, dated January 5, 2024
Sales Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2024
Amendment No. 1 to Amended and Restated Clinical Collaboration and Supply Agreement, by and between the Company and Novartis Institutes for BioMedical Research, Inc., dated...
Collaboration Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2023
Loan and Security Agreement, dated September 5, 2023, by and between the Company and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company
Loan Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2023
Stock Purchase Agreement, dated September 5, 2023, by and among the Company and the Purchasers named therein
Stock Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
NY
2023
Separation Agreement by and between the Registrant and Kinney Horn, dated March 8, 2023
Separation Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2023
Separation Agreement by and between the Registrant and Cyrus Harmon, dated March 21, 2023
Separation Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2023
Amended and Restated Clinical Collaboration and Supply Agreement, by and between the Registrant and Novartis Institutes for BioMedical Research, Inc., dated January 13, 2022
Collaboration Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
NY
2023
Sales Agreement by and between Registrant and Oppenheimer & Co. Inc., dated March 9, 2023
Sales Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2023
Drug Discovery Collaboration and License Agreement by and between the Registrant and Aurigene Discovery Technologies Limited, dated June 7, 2022
Collaboration Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
NY
2022
Olema Pharmaceuticals, Inc. 2022 Inducement Plan
Olema Pharmaceuticals, Inc.
Biotechnology
DE
2022
Offer Letter by and between the Registrant and Naseem Zojwalla, dated December 15, 2021
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2022
Form of Stock Option Agreement and Option Grant Notice under the Inducement Plan
Stock Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2022
Consulting Agreement by and between the Company and Frank McCormick Ph.D., F.R.S., D.Sc. (Hon), dated April 5, 2021
Consulting Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2021
Description of Capital Stock
Stock Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2021
Olema Pharmaceuticals, Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
DE
2020
Form of Underwriting Agreement
Underwriting Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2020
Form of Common Stock Certificate
Stock Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2020
Olema Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan
Stock Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2020
Olema Pharmaceuticals, Inc. 2020 Non-Employee Director Compensation Policy
Compensation Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2020
Amended and Restated Offer Letter by and between the Registrant and Sean Bohen, dated November 13, 2020
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2020
Amended and Restated Offer Letter by and between the Registrant and Cyrus L. Harmon, dated November 13, 2020
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2020
Amended and Restated Offer Letter by and between the Registrant and Kinney Horn, dated November 13, 2020
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2020
Amended and Restated Offer Letter by and between the Registrant and Shane Kovacs, dated November 13, 2020
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2020
Amended and Restated Offer Letter by and between the Registrant and Peter Kushner, dated November 13, 2020
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2020
Amended and Restated Offer Letter by and between the Registrant and David Myles, dated November 13, 2020
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2020
Amended and Restated Offer Letter by and between the Registrant and John B. Moriarty, Jr., dated November 13, 2020
Olema Pharmaceuticals, Inc.
Biotechnology
CA
2020
Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated September 30, 2020
Investor Rights Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
DE
2020
Clinical Collaboration and Supply Agreement by and between the Registrant and Novartis Institutes for BioMedical Research, Inc., dated July 22, 2020
Collaboration Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
NY
2020
Form of Indemnification Agreement by and between the Registrant and its directors and executive officers
Indemnification Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
DE
2020
Olema Pharmaceuticals, Inc. 2020 Non-Employee Director Compensation Policy
Compensation Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2020
Olema Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan
Stock Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2020
Forms of Restricted Stock Unit Grant Notice and Award Agreement under the Olema Pharmaceuticals, Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2020
Forms of Stock Option Grant Notice and Stock Option Agreement under the Olema Pharmaceuticals, Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
2020
Olema Pharmaceuticals, Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
DE
2020
Forms of Stock Option Grant Notice, Stock Option Agreement, Early Exercise Stock Purchase Agreement and Notice of Exercise and Restricted Stock Award Grant Notice and Restricted...
Stock Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
DE
2020
Olema Pharmaceuticals, Inc. 2014 Stock Plan, as amended
Stock Agreements
Olema Pharmaceuticals, Inc.
Biotechnology
DE
2020